Recombinant Scorpine Produced Using SUMO Fusion Partner in Escherichia Coli Has the Activities Against Clinically Isolated Bacteria and Inhibits the Plasmodium Falciparum Parasitemia in Vitro

PLoS ONE - United States
doi 10.1371/journal.pone.0103456
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

In Vitro Synthesis of 9,10-Dihydroxyhexadecanoic Acid Using Recombinant Escherichia Coli

Microbial Cell Factories
Applied MicrobiologyBiotechnologyBioengineering
2017English

Antigenic Cross-Reactivity of Plasmodium Falciparum Antigens Expressed in Escherichia Coli

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
1986English

In Vitro Activities of Chloroquine in Combination With Chlorpromazine or Prochlorperazine Against Isolates of Plasmodium Falciparum.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1992English

Enhanced in Vitro Refolding of Fibroblast Growth Factor 15 With the Assistance of SUMO Fusion Partner

PLoS ONE
Multidisciplinary
2011English

Spontaneous Postpartum Clearance of Plasmodium Falciparum Parasitemia in Pregnant Women, Benin

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2011English

Mode of Action of Tubulozoles Against Plasmodium Falciparum in Vitro.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1990English

In Vitro Activity of Fosfomycin Against Escherichia Coli Strains Isolated From Urinary System Infections

ANKEM Dergisi
2015English

The Efficient Solubilization and Refolding of Recombinant Organophosphorus Hydrolyses Inclusion Bodies Produced in Escherichia Coli

Journal of Applied Biotechnology Reports
Biotechnology
2019English

Stadium Dan Tingkat Parasitemia Plasmodium Falciparum Pada Sediaan Darah Malaria

Jaringan Laboratorium Medis
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy